Isthmus Partners, LLC Novartis Ag Transaction History

Isthmus Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 04, 2019	SELL	$73.66 - $82.02 $47,510 - $52,902	-645 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $43,176 - $49,942	645 New	645 $56,000
Q4 2017 Feb 05, 2018	SELL	$72.33 - $77.64 $28,932 - $31,056	-400 Closed	0 $0
Q3 2017 Nov 02, 2017	BUY	$74.14 - $77.27 $29,656 - $30,908	400	400 $34,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Isthmus Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Isthmus Partners, LLC with notifications on news.